TREACE MEDICAL CONCEPTS, INC. (TMCI)

6.38 0 (0%)

As of 2025-10-16 15:10:05 EST

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

Traded asNasdaq: TMCI
ISINUS89455T1097
CIK0001630627
LEI—
EIN471052611
SectorMedical devices
IndustrySurgical & Medical Instruments & Apparatus
CEOJohn T. Treace
Employees133
Fiscal Year End1231
Address100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
Phone(904) 373-5940
Websitehttp://treace.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
TMCITREACE MEDICAL CONCEPTS, INC.2025-10-16 15:10:056.3800
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
TMCI0001630627TREACE MEDICAL CONCEPTS, INC.US89455T1097—471052611Nasdaq3841Surgical & Medical Instruments & Apparatus1231FL100 PALMETTO PARK PLACEPONTE VEDRAFL32081UNITED STATESUS(904) 373-5940100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081—Medical devices2014John T. Treace133http://treace.com309,800,00063,120,20463,173,126Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.2025-10-10 21:49:08
This is a preview of the latest data. Subscribe to access the full data.
TMCI Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
TMCI Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024309,800,000-913,800,000-74.681362,618,725863,5791.3984
20231,223,600,000697,400,000132.535261,755,146599,0760.9796
2022526,200,000525,350,10061,813.166361,156,0706,407,87011.7043
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Scot M. ElderCorporate Secretary2024409,26203,571,932150,6195,6764,550,615
Gaetano M. GuglielminoChief Commercial Officer202437,268100,0003,092,7600703,230,098
John T. TreaceFounder, Director, Chief Executive Officer2024723,41005,768,81489,88015,0566,597,160
Mark L. HairChief Financial Officer2024490,08203,327,57330,55711,2684,485,302
John T. TreaceFounder, Director, Chief Executive Officer2023684,38405,350,966393,00016,6968,422,635
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024477
2023516
2022423
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue209,357,000187,118,000141,838,000
Cost Of Revenue41,093,00035,181,00027,523,000
Gross Profit168,264,000151,937,000114,315,000
Research And Development Expenses20,589,00015,440,00013,584,000
General And Administrative Expenses55,720,00047,031,00032,999,000
Operating Expenses223,952,000203,365,000149,159,000
Operating Income-55,688,000-51,428,000-34,844,000
Net Income-55,743,000-49,527,000-42,815,000
Earnings Per Share Basic-0.9-0.81-0.77
Earnings Per Share Diluted-0.9-0.81-0.77
Weighted Average Shares Outstanding Basic62,112,03760,852,15355,276,834
Weighted Average Shares Outstanding Diluted62,112,03760,852,15355,276,834
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents11,350,00012,982,00019,473,000
Marketable Securities Current64,327,000110,216,00061,779,000
Accounts Receivable40,803,00038,063,00029,196,000
Inventories39,255,00029,245,00019,330,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current161,402,000198,359,000133,402,000
Marketable Securities Non Current———
Property Plant And Equipment25,953,00022,298,00015,338,000
Other Assets Non Current407,000146,000146,000
Total Assets Non Current55,692,00053,548,00025,622,000
Total Assets217,094,000251,907,000159,024,000
Accounts Payable10,522,00011,835,0008,668,000
Deferred Revenue———
Short Term Debt000
Other Liabilities Current7,197,00010,458,0006,216,000
Total Liabilities Current34,925,00045,033,00030,245,000
Long Term Debt53,306,00053,008,00052,711,000
Other Liabilities Non Current37,00037,000—
Total Liabilities Non Current69,277,00068,936,00068,250,000
Total Liabilities104,202,000113,969,00098,495,000
Common Stock62,00062,00055,000
Retained Earnings-189,990,000-134,247,000-84,720,000
Accumulated Other Comprehensive Income97,000163,000-27,000
Total Shareholders Equity112,892,000137,938,00060,529,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization8,419,0005,352,0002,133,000
Share Based Compensation Expense30,603,00017,352,0008,111,000
Other Non Cash Income Expense-538,000-205,000-25,000
Change In Accounts Receivable5,687,0009,301,00011,039,000
Change In Inventories10,010,0009,848,0008,769,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable-1,313,0003,167,0004,612,000
Change In Other Liabilities-97,000-119,0007,125,000
Cash From Operating Activities-37,167,000-34,575,000-30,648,000
Purchases Of Marketable Securities71,579,000169,865,00063,409,000
Sales Of Marketable Securities118,547,000120,024,0001,729,000
Acquisition Of Property Plant And Equipment11,593,00011,458,00014,838,000
Acquisition Of Business020,000,000—
Other Investing Activities———
Cash From Investing Activities35,375,000-81,299,000-76,518,000
Tax Withholding For Share Based Compensation268,00013,000—
Payments Of Dividends———
Issuance Of Common Stock——0
Repurchase Of Common Stock———
Issuance Of Long Term Debt——0
Repayment Of Long Term Debt—00
Other Financing Activities———
Cash From Financing Activities160,000109,383,00020,806,000
Change In Cash-1,632,000-6,491,000-86,360,000
Cash At End Of Period11,350,00012,982,00019,473,000
Income Taxes Paid———
Interest Paid4,955,0005,167,0004,398,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-0.9-0.81-0.77
Price To Earnings Ratio-8.2667-15.7407-29.8571
Earnings Growth Rate11.11115.1948—
Price Earnings To Growth Ratio-0.744-3.0301—
Book Value Per Share1.81762.26681.095
Price To Book Ratio4.09345.624720.9951
Ebitda-42,068,000-39,008,000-36,284,000
Enterprise Value504,069,555.28815,890,950.751,304,052,413.66
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.47220.38430.8708
Capital Expenditures12,074,00012,312,00014,622,000
Free Cash Flow-49,241,000-46,887,000-45,270,000
Return On Equity-0.4938-0.3591-0.7073
One Year Beta2.28451.17241.4059
Three Year Beta1.49731.24561.2716
Five Year Beta1.4041.24561.2716
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Elder Scot MichaelChief Legl & Comp Off, CorpSec2025-10-02650D549,265
Elder Scot MichaelChief Legl & Comp Off, CorpSec2025-09-3016,234D549,915
Berutti AaronSVP, Sales2025-08-094,907D205,092
Scanlan Sean F.Chief Innovation Officer2025-08-099,814D373,807
Hair MarkChief Financial Officer2025-08-0922,212D518,964
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
CWM, LLC2025-09-3068,00010,1786.6811
Stephens Consulting, LLC2025-09-303,1744736.7104
Farther Finance Advisors, LLC2025-09-304,6846986.7106
GAMMA Investing LLC2025-09-303,0404536.7108
NEW YORK STATE COMMON RETIREMENT FUND2025-06-3042,2247,1815.88
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Grandeur Peak Global Trust2025-07-31Institutional ClassGPMCX37,399200,832.630.4297
Advisors' Inner Circle Fund III2025-07-31I SharesKCXIX2041,095.480.0005
Global X Funds2025-07-31Global X Russell 2000 ETFRSSL24,135129,604.950.0099
FIDELITY CONCORD STREET TRUST2025-07-31Fidelity ZERO Total Market Index FundFZROX22,959123,289.830.0004
FIDELITY CONCORD STREET TRUST2025-07-31Fidelity ZERO Extended Market Index FundFZIPX13,60773,069.590.004
This is a preview of the latest data. Subscribe to access the full data.